Precerebellin, or CBLN1, is the precursor of a conserved brain-specific hexadecapeptide termed cerebellin. CBLN1 and other members of the precerebellin family also contain a C-terminal C1q signature domain that mediates trimeric assembly of atypical collagen complexes. The deduced 193-amino acid protein contains a hydrophobic N terminus followed by the cerebellin sequence. It also contains 3 potential N-glycosylation sites. Over about 145 amino acids in its C terminus, CBLN1 shares 31.3% identity with C1QB , but it lacks N-terminal collagen-like motifs. The cerebellin peptide is flanked by val-arg and glu-pro residues, suggesting that it is not liberated from precerebellin by the classical dibasic amino acid proteolytic mechanism seen in many neuropeptide precursors.

Human Cerebellin-1 (CBLN1) ELISA Kit employs a two-site sandwich ELISA to quantitate CBLN1 in samples. An antibody specific for CBLN1 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyCBLN1 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for CBLN1 is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of CBLN1 bound in the initial step. The color development is stopped and the intensity of the color is measured.

Human Cerebellin-1 (CBLN1) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/human-cerebellin-1-cbln1-elisa-kit-kte62429/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.